<!-- 
Generated by: gemini
Model: gemini-2.5-pro-preview-06-05
Prompt type: sources
Tools enabled: False
Generated at: 2025-06-26T22:29:34.299583
-->

*This response was generated by **Gemini** (gemini-2.5-pro-preview-06-05) using the provided sources.*

[← Back to Question README](README.md) | [← Back to Index](../README.md) | [View All Sources](../allsources.md)

*Want to add more sources or suggest new questions? [Contribute on GitHub](https://github.com/justinwest/SuggestedSources)*

---

# Does gender affirming care lower youth suicide risk?

The question of whether gender-affirming care lowers suicide risk in youth is a subject of significant medical and scientific debate. While some studies indicate a positive correlation between access to care and improved mental health outcomes, including reduced suicidality, other major systematic reviews and analyses have concluded that the evidence is of low quality and insufficient to establish a causal link. The provided sources reflect this ongoing disagreement.

### Evidence Suggesting a Reduced Risk of Suicide

Several observational studies suggest that gender-affirming medical care is associated with better mental health outcomes for transgender youth.

*   A 2022 study in *JAMA Network Open* followed 104 transgender and nonbinary youths aged 13-20. It found that after a 12-month period, the group that received gender-affirming medical care (puberty blockers or hormones) had 60% lower odds of moderate to severe depression and 73% lower odds of suicidality compared to the group that did not [6].
*   A 2020 study in *Pediatrics* surveyed 20,619 transgender adults and found that those who had wanted and received pubertal suppression during adolescence had lower odds of lifetime suicidal ideation compared to those who wanted it but did not receive it [1].

### Evidence Suggesting Nuanced or No Improvement

Other studies have produced more ambiguous results, suggesting that while some aspects of well-being may improve, core mental health metrics like depression and anxiety may not.

*   A 2023 study published in the *New England Journal of Medicine* followed 315 transgender youth for two years after they started hormone treatment. The study found that while participants' appearance congruence and life satisfaction increased, their scores for anxiety and depression did not show a statistically significant improvement over the study period [7].
*   A 2024 study in *The Journal of Sexual Medicine* examined mental health outcomes after gender-affirming surgery using a national database. It found "no mental health benefit of gender-affirming surgery" for either transmasculine or transfeminine individuals when analyzing rates of outpatient mental health visits and psychiatric medication prescriptions [5].

### Critiques and Concerns About Evidence Quality

Several comprehensive reviews have raised significant concerns about the methodological quality and reliability of the existing research.

*   The **Cass Review**, an independent review commissioned by England's National Health Service (NHS), concluded in its interim report that the evidence base for medical interventions for gender-diverse youth is "remarkably weak" and "inconclusive" [3]. The review noted a lack of long-term follow-up studies, the confounding factor of co-occurring mental health conditions, and the inability of existing studies to differentiate the effects of medical treatment from the effects of psychosocial support. Due to these evidence gaps, the review recommended a more cautious clinical approach [3].
*   An internal review conducted for the **U.S. Department of Health and Human Services (HHS)**, and later made public, systematically evaluated existing studies on pediatric gender-affirming care. Its author concluded that the available evidence is of "low-quality" and that a causal relationship between medical interventions and improved mental health cannot be established [4, 8]. The review highlighted methodological flaws in the research, such as the risk of bias and the lack of appropriate control groups, making it difficult to draw firm conclusions about the benefits and risks of treatment [4].
*   The methodology of some key studies has also been a point of contention. For example, a critique of the 2022 *JAMA Network Open* study argued that the researchers' raw clinical data did not show a statistically significant improvement in mental health among the youth who received care. The article alleges that the positive finding was achieved by comparing the treatment group to a separate, external survey group rather than to the study's own control group, a methodological choice the critic deemed inappropriate [2].

In conclusion, while some studies correlate gender-affirming care with lower suicide risk, this finding is not consistently supported across all research. Major systematic reviews from health bodies like the NHS have found the overall evidence base to be weak and inconclusive, preventing a definitive scientific consensus on whether gender-affirming care causally reduces suicide risk in youth [3, 4].

***

### Sources

1.  **Turban, J. L., et al. "Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation." *Pediatrics***
    *   **Author's View:** Summarizes that this study of transgender adults found an association between having received pubertal suppression in adolescence and lower odds of lifetime suicidal ideation.
    *   **URL:** [`https://publications.aap.org/pediatrics/article-abstract/145/2/e20191725/68259/Pubertal-Suppression-for-Transgender-Youth-and?redirectedFrom=fulltext`](https://publications.aap.org/pediatrics/article-abstract/145/2/e20191725/68259/Pubertal-Suppression-for-Transgender-Youth-and?redirectedFrom=fulltext)
2.  **Singal, J. "Researchers Found Puberty Blockers and Hormones Didn’t Improve Trans Kids’ Mental Health at Their Clinic — Then They Published a Study Claiming the Opposite." *Singal-Minded***
    *   **Author's View:** Summarizes that this article critiques the methodology of a prominent study (Tordoff et al. in JAMA), arguing that the study's own clinical data did not show a statistically significant mental health benefit and that the positive published findings were achieved by using a different comparison group.
    *   **URL:** [`https://jessesingal.substack.com/p/researchers-found-puberty-blockers`](https://jessesingal.substack.com/p/researchers-found-puberty-blockers)
3.  **Dr. Hilary Cass. "Independent Review of Gender Identity Services for Children and Young People: Interim Report." *Cass Review (NHS England)***
    *   **Author's View:** Summarizes that this independent review for NHS England concluded that the evidence base for gender-affirming medical treatments for youth is "remarkably weak," citing a lack of long-term studies and poor-quality evidence. It calls for a more cautious approach and robust data collection.
    *   **URL:** [`https://webarchive.nationalarchives.gov.uk/ukgwa/20250310143846mp_/https://cass.independent-review.uk/wp-content/uploads/2022/03/Cass-Review-Interim-Report-Final-Web-Accessible.pdf`](https://webarchive.nationalarchives.gov.uk/ukgwa/20250310143846mp_/https://cass.independent-review.uk/wp-content/uploads/2022/03/Cass-Review-Interim-Report-Final-Web-Accessible.pdf)
4.  **Blair, P. "Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices." *U.S. Department of Health and Human Services***
    *   **Author's View:** Summarizes that this internal HHS evidence review determined that the existing research on the benefits of medical interventions for youth with gender dysphoria is of "low-quality" and insufficient to establish a causal link to improved mental health.
    *   **URL:** [`https://archive.jwest.org/Research/DHHS2025-GenderDysphoria.pdf`](https://archive.jwest.org/Research/DHHS2025-GenderDysphoria.pdf)
5.  **Garthe, K., et al. "Examining Gender-Specific Mental Health Risks After Gender-Affirming Surgery: A National Database Study." *The Journal of Sexual Medicine***
    *   **Author's View:** Summarizes that this study of a national database found no evidence of mental health benefits (measured by outpatient visits and medication prescriptions) following gender-affirming surgery for either transmasculine or transfeminine individuals.
    *   **URL:** [`https://academic.oup.com/jsm/article-abstract/22/4/645/8042063`](https://academic.oup.com/jsm/article-abstract/22/4/645/8042063)
6.  **Tordoff, D. M., et al. "Mental Health Outcomes in Transgender and Nonbinary Youths Receiving Gender-Affirming Care." *JAMA Network Open***
    *   **Author's View:** Summarizes that this study found that receiving gender-affirming medical care (puberty blockers or hormones) was associated with significantly lower odds of depression and suicidality in transgender and nonbinary youth over a 12-month period.
    *   **URL:** [`https://pubmed.ncbi.nlm.nih.gov/35212746/`](https://pubmed.ncbi.nlm.nih.gov/35212746/)
7.  **Chen, D., et al. "Psychosocial Functioning in Transgender Youth after 2 Years of Hormones." *New England Journal of Medicine***
    *   **Author's View:** Summarizes that this study found that after two years of hormone therapy, transgender youth reported higher life satisfaction and congruence with their appearance, but their levels of depression and anxiety did not show a statistically significant change.
    *   **URL:** [`https://pubmed.ncbi.nlm.nih.gov/36652355/`](https://pubmed.ncbi.nlm.nih.gov/36652355/)
8.  **Anonymous. "I'm a public health expert. The evidence for transitioning kids is thin." *The Washington Post***
    *   **Author's View:** Summarizes the perspective of the author of the internal HHS review [4], who argues that the evidence supporting medical transition for minors is weak and that the politicization of the topic has stifled open scientific debate.
    *   **URL:** [`https://www.washingtonpost.com/opinions/2025/06/26/hhs-review-anonymous-author/`](https://www.washingtonpost.com/opinions/2025/06/26/hhs-review-anonymous-author/)